Posts by: admin

News

Researchers at the Barts Cancer Institute, Queen Mary University of London, have shown that combining virotherapy and immunotherapy can have a significant impact for the treatment of pancreatic cancer. The ... Read more

December 30, 2014

Selecta Will Receive Skolkovo Foundation Grant To Develop A Synthetic Vaccine Particle

News

Selecta Biosciences has announced it will receive a $3.2 million grant from Skolkovo Foundation to support a Synthetic Vaccine Particle (SVP) immunotherapy targeted at cancers originated by infections with Human ... Read more

December 26, 2014December 26, 2014

Researchers Identify Pro-Tumoral Cells That Suppress Immune Responses

News

In a recent study published in the journal Immunity, a team of researchers from St. Jude Children’s Research Hospital characterized a family of immune cells that are used by tumors ... Read more

December 23, 2014December 23, 2014

Endogenous Retroviruses Linked to Benefic Immune Responses

News

UT Southwestern Medical Center researchers, in collaboration with colleagues from the Karolinska Institutet in Stockholm, Sweden, have published the results of a recent study in Science, titled “MAVS, cGAS, and ... Read more

December 22, 2014December 22, 2014

Researchers Develop New Synthetic Molecules That Can Mimic Antibodies

News

A recent study titled “Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies” and published in the Journal of the American Chemical Society by Yale University researchers, showed ... Read more

December 19, 2014December 19, 2014

Researchers Find Two Pre-Surgical Drugs That Help Women With Triple-Negative Breast Cancer

News

Recent research presented at the 2014 San Antonio Breast Cancer Symposium, showed that the addition of either carboplatin (chemotherapy drug) or bevacizumab (monoclonal anti-VEGF antibody) to standard chemotherapy treatment before ... Read more

December 18, 2014December 18, 2014

Sorrento Therapeutics Forms Collaboration For The Development Of Cancer Immunotherapies

News

Sorrento Therapeutics, Inc. has announced a contract with NantWorks founder, Dr. Patrick Soon-Shiong, to strategically collaborate in the development of innovative immunotherapies for treating both cancer and autoimmune diseases. Both parties want ... Read more

December 17, 2014December 17, 2014

Study Finds Antibody Shape Matters In Cancer Immunotherapy

News

In a recent study published in the journal Cancer Cell, a team of researchers from the University of Southampton found that the exact shape of an antibody can be extremely ... Read more

December 10, 2014December 10, 2014

Sleeping Beauty Gene Shows Promising Results In lymphoid Malignancies

News

During the 56th Annual Meeting of the American Society of Hematology (ASH) conference in San Francisco, researchers from the University of Texas MD Anderson Cancer Center presented their latest clinical ... Read more

December 9, 2014December 9, 2014

Cell Source’s Veto Cell Technology As An Innovative Cell Therapy for Blood Cancers

News

A new cellular technology from Cell Source, an immunotherapy company, is being studied by researchers for the treatment of blood cancer and bone marrow transplantation. Veto Cell technology, or T ... Read more